Drew G M
Eur J Pharmacol. 1976 Apr;36(2):313-20. doi: 10.1016/0014-2999(76)90084-4.
The effects of alpha adrenoceptor agonists and antagonists have been examined at pre- and post-synaptically located alpha-adrenoceptors in the pithed rat. The presynaptic receptors were those located at the cardiac sympathetic nerve terminals and the postsynaptic receptors were those present in vascular smooth muscle. Clonidine was approximately equipotent at pre- and post-synaptic alpha-adrenoceptors, whilst LSD and BAY-1470 were more active at the pre- than at post-synaptic sites. Oxymetazoline, naphazoline, methoxamine and phenylephrine were all much more active at the postsynaptic alpha-adrenoceptors. Phentolamine was the most potent antagonist at both pre- and post-synaptic alpha-adrenoceptors. Piperoxan, yohimbine and tolazoline were about 3-7X less potent than phentolamine at both sites. Thymoxamine was about 10X less potent than phentolamine at postsynaptic alpha-adrenoceptors but about 1000X less active at the presynaptic receptors. The differential actions of both agonsists and antagonists at pre- and post-synaptic alpha-adrenoceptors suggest that the receptors may be of different types.
在脊髓麻醉大鼠中,已研究了α肾上腺素能受体激动剂和拮抗剂对突触前和突触后α肾上腺素能受体的作用。突触前受体位于心脏交感神经末梢,突触后受体存在于血管平滑肌中。可乐定对突触前和突触后α肾上腺素能受体的作用大致相当,而LSD和BAY - 1470在突触前比在突触后部位更具活性。羟甲唑啉、萘甲唑啉、甲氧明和去氧肾上腺素在突触后α肾上腺素能受体上的活性都高得多。酚妥拉明是突触前和突触后α肾上腺素能受体上最有效的拮抗剂。哌罗克生、育亨宾和妥拉唑啉在这两个部位的效力比酚妥拉明低约3 - 7倍。噻吗洛尔在突触后α肾上腺素能受体上的效力比酚妥拉明低约10倍,但在突触前受体上的活性比酚妥拉明低约1000倍。激动剂和拮抗剂在突触前和突触后α肾上腺素能受体上的不同作用表明这些受体可能是不同类型的。